Kerala Ayurveda Ltd
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]
- Market Cap ₹ 593 Cr.
- Current Price ₹ 493
- High / Low ₹ 502 / 250
- Stock P/E
- Book Value ₹ 7.89
- Dividend Yield 0.00 %
- ROCE -8.75 %
- ROE -67.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 62.5 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 9.40% over past five years.
- Company has a low return on equity of -38.0% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
35 | 39 | 46 | 50 | 59 | 59 | 77 | 62 | 80 | 93 | 108 | 120 | |
31 | 33 | 38 | 43 | 51 | 54 | 69 | 61 | 71 | 91 | 101 | 125 | |
Operating Profit | 4 | 6 | 8 | 7 | 8 | 5 | 7 | 1 | 10 | 3 | 7 | -5 |
OPM % | 11% | 15% | 16% | 14% | 14% | 9% | 10% | 1% | 12% | 3% | 6% | -4% |
0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 3 | 1 | 2 | |
Interest | 1 | 2 | 2 | 1 | 2 | 3 | 2 | 6 | 7 | 5 | 5 | 4 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 5 |
Profit before tax | 2 | 3 | 4 | 4 | 4 | 3 | 5 | -7 | 3 | -1 | 1 | -12 |
Tax % | 48% | 21% | 33% | 22% | 31% | 19% | 11% | -28% | 15% | -23% | 168% | 14% |
1 | 3 | 3 | 3 | 3 | 3 | 4 | -5 | 2 | -0 | -1 | -14 | |
EPS in Rs | 0.70 | 2.24 | 2.56 | 2.90 | 2.66 | 2.31 | 3.69 | -4.59 | 2.24 | -0.85 | -1.27 | -12.22 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 14% |
TTM: | 12% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -1505% |
Stock Price CAGR | |
---|---|
10 Years: | 30% |
5 Years: | 50% |
3 Years: | 92% |
1 Year: | 63% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -37% |
3 Years: | -38% |
Last Year: | -67% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 12 |
Reserves | -21 | -19 | -17 | -4 | -3 | -7 | -3 | -7 | -4 | -5 | 20 | -3 |
66 | 70 | 69 | 56 | 75 | 62 | 64 | 77 | 70 | 72 | 68 | 71 | |
11 | 11 | 11 | 17 | 20 | 27 | 31 | 34 | 34 | 37 | 41 | 49 | |
Total Liabilities | 66 | 73 | 73 | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 141 | 129 |
35 | 33 | 34 | 34 | 32 | 33 | 33 | 33 | 44 | 46 | 46 | 47 | |
CWIP | 0 | 0 | 0 | 6 | 11 | 12 | 14 | 14 | 4 | 7 | 7 | 9 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
32 | 40 | 39 | 41 | 59 | 47 | 56 | 68 | 62 | 61 | 88 | 73 | |
Total Assets | 66 | 73 | 73 | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 141 | 129 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | 0 | 6 | 4 | -10 | 12 | 5 | 7 | -0 | 10 | 2 | 5 | |
-1 | -0 | -3 | -3 | -3 | -3 | -4 | -1 | -2 | -7 | -1 | -15 | |
1 | 2 | -2 | 0 | 17 | -12 | 1 | 6 | -13 | -1 | 18 | -9 | |
Net Cash Flow | -1 | 2 | -0 | 1 | 4 | -2 | 2 | 12 | -16 | 2 | 18 | -19 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 36 | 35 | 33 | 35 | 34 | 43 | 51 | 61 | 61 | 51 | 53 | 59 |
Inventory Days | 413 | 287 | 227 | 319 | 338 | 311 | 313 | 268 | 254 | 227 | 258 | 208 |
Days Payable | 245 | 150 | 100 | 112 | 125 | 117 | 162 | 149 | 168 | 137 | 129 | 93 |
Cash Conversion Cycle | 204 | 172 | 160 | 242 | 247 | 236 | 202 | 179 | 147 | 141 | 182 | 174 |
Working Capital Days | 5 | 19 | 26 | 49 | 138 | 50 | 37 | 8 | 30 | 5 | 17 | -7 |
ROCE % | 5% | 8% | 9% | 9% | 9% | 6% | 9% | -0% | 11% | 2% | 6% | -9% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 17h
- Corrigendum To EGM Notice 2d
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
2 Jun - Kerala Ayurveda's subsidiary acquired 51% stake in Singapore-based OM VEDIC HERITAGE for SGD 2.8L.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY25 with multiple regulatory non-compliances and governance issues.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 28 May
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
Business Overview:[1]
Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants